MUTUAL FUND
19 August, 2026
GSK Eyes AnaptysBio Acquisition to Secure Drug Control
Greenhaven Road Capital's Q2 2026 investor letter highlights AnaptysBio, Inc. (NASDAQ:ANAB) as a newly added position, emphasizing the company's unique business model…